A n important process in regulating heart rate and excitation-contraction coupling by sympathetic nerves is the stimulation of the high-threshold (L-type) Ca 2ϩ current (I CaL ) by ␤-adrenergic agonists. In adult mammalian cardiomyocytes, the signal transduction from receptor to the channel includes several steps of interaction of functionally coupled downstream components ( Figure 1 ). Binding of an agonist to the ␤-adrenoceptor activates a guanine nucleotidebinding (G) protein, G s , which triggers the activation of adenylyl cyclase (AC) and, in turn, increases the level of cytosolic cAMP. 1 This is followed by the phosphorylation of the Ca 2ϩ channel through the activation of cAMPdependent protein kinase A (PKA), 2, 3 leading to an increase in channel open probability and channel availability. 4 However, a direct stimulation of Ca 2ϩ channels via G s protein was also suggested. 5 Despite recent advances in the understanding of the ␤-adrenergic modulation of the Ca 2ϩ channel during embryonic 6 and postnatal development, 7 the establishment of this important signaling cascade during cardiomyocyte development is still unresolved. Moreover, studies on isolated cardiomyocytes highlighted the importance of the impaired ␤-adrenergic modulation in cardiac disorders, such as heart hypertrophy and heart failure. 8, 9 The detailed knowledge about cardiomyocytes of early developmental stages has now become of particular interest, because recent studies show that cardiomyocytes of failing hearts tend to dedifferentiate toward an embryonic phenotype (see References 10 and 11) . On the other hand, dysfunctions in adult cells may stem from activation of a dormant pathway developed earlier during cellular differentiation.
The aim of the present study was to investigate the establishment of the ␤-adrenergic signaling cascade for early cardiomyocyte development. Because of the known difficulties to obtain cardiomyocytes of the very early developmental stages from the mammalian embryos (eg, before day 12 to 13 of gestation in mouse), we have used for the present study an in vitro model of cardiomyogenesis based on pluripotent mouse embryonic stem (ES) cells. The cardiomyogenesis observed in ES cell-derived embryoid bodies (EBs) is almost identical to mouse embryo 12 during early stages of development. Moreover, late-stage ES cell-derived cardiomyocytes exhibit rod-shaped morphology, sarcomere formation, and cell-cell junctions similar to those observed in cardiac myocytes developing in vivo. 13 The electrophysiological characteristics in late developmental stage ES cell-derived cardiomyocytes are identical to postnatal cardiomyocytes. 14 -16 The normal course of development of cardiomyocytes from ES cells has been recently corroborated by the finding that implanted ES cell-derived cardiomyocytes form stable functional grafts in the hearts of adult mice. 17, 18 The ES cell differentiation model provides the unique possibility to examine the role of particular components involved in signal transduction at different time points during cardiomyogenesis. 19, 20 Early-stage ES cell-derived cardiomyocytes express I CaL as well as the delayed rectifying K ϩ current. These currents were regulated by both ␤-adrenergic and muscarinic signaling pathways, suggesting the normal course of development for signaling components. 16 In preliminary experiments, we found a strong developmental increase in the chronotropic response of EBs to ␤-adrenergic stimulation. 14 Therefore, in the present study, the modulation of I CaL was used as a functional assay to test different components of the ␤-adrenergic signaling cascade during cardiomyocyte development (Figure 1 ).
Materials and Methods

Cell Cultures, Differentiation Procedure, and Preparation of Single Cardiomyocytes
The ES cell line D3 21 was used throughout the present study. These cells were cultivated and differentiated into spontaneously beating cardiomyocytes as previously described. 14 -16 Briefly, ES cells were kept in an undifferentiated, pluripotent state using mitomycin C-inactivated feeder layer of primary cultures of mouse embryonic fibroblasts. They were cultivated on gelatin (0.1%)-coated plastic Petri dishes in DMEM supplemented with 15% FCS (selected batches), L-glutamine (2 mmol/L), and nonessential amino acids. The main steps of differentiation included the following: (1) the cultivation of a definite number of cells (400) in "hanging drops" as EBs for 2 days, (2) cultivation as suspension in bacteriological dishes for 5 days, (3) plating of 7 days' (7d) EBs on 24 -well-microwell plates. About 10% of these 7d EBs already contained contracting cardiomyocytes. In EB outgrowths, cardiomyocytes appeared in the form of spontaneously contracting cell clusters. The clusters increased in size during differentiation. Single cardiomyocytes were isolated from the clusters by enzymatic dissociation with collagenase using a modified procedure of Isenberg and Klöckner 22 described previously. 16 Cardiomyocytes were isolated at 3 distinct developmental stages: (1) the very early developmental stage (VEDS), when first spontaneously contracting clusters of cardiomyocytes appeared (from 7ϩ1d to 7ϩ2d), (2) the early developmental stage (EDS) (from 7ϩ3d to 7ϩ5d), and (3) the late developmental stage (LDS) (from 7ϩ9d to 7ϩ12d). Ventricular cardiomyocytes were isolated from adult mice by collagenase treatment as previously reported. 22 
Stable Recording of I CaL by Whole-Cell Patch-Clamp Technique
The whole-cell configuration of the patch-clamp technique 23 was used throughout the present study. This configuration allowed the cell to be dialyzed with various compounds, testing the development of different components of the ␤-adrenergic signaling cascade. Stimulation effects of I CaL were measured when I CaL rundown was minimized. Fast rundown of Ca 2ϩ channel current has been previously reported in embryonic mouse cardiomyocytes when Ba 2ϩ was used as a charge carrier. 6 This was also true for cardiomyocytes differentiated from ES cells (authors' recent unpublished observation). However, we found that I CaL rundown was smaller when Ca 2ϩ was used as a charge carrier. Furthermore, the intracellular ATP concentration was raised to 5 mmol/L to minimize I CaL rundown. 24 Under these conditions, the decrease in I CaL amplitude was small particularly during the first 10 minutes after establishment of the whole-cell configuration using 1.8 mmol/L Ca 2ϩ as a charge carrier. As previously reported, 16 the size of cardiomyocytes increases during development. For the developmental stages characterized in the present study, VEDS, EDS, and LDS, the average membrane capacities were 19.5Ϯ1.4 pF (nϭ16), 29.2Ϯ1.7 (nϭ39), and 35.9Ϯ2.4 pF (nϭ58), respectively. Because cell constituents may be washed out more rapidly in smaller cells and lead to possible artifacts, we ensured that this was insignificant for our investigations on I CaL stimulation. Indeed, the isoproterenol effect on I CaL measured at 5 and 20 minutes after establishment of the whole-cell configuration was identical (difference Ͻ10%, nϭ8; data not shown). Furthermore, although cell dialysis depends even more on pipette and tetraethylammonium, respectively, to effectively block K ϩ current. The I CaL peak was measured repetitively at a test potential of 0 mV for 300 or 20 ms from a holding potential of Ϫ40 or Ϫ50 mV. For the recording of the time course of peak I CaL , depolarizing voltage pulses were applied at a frequency of 0.2 Hz. To evaluate the degree of I CaL stimulation, the maximum I CaL density was taken before and after drug application. The stimulation of I CaL is reported in terms of the percentage of the increase of I CaL density. The average stimulation effect at a given developmental stage was calculated by averaging individual cell responses. If not stated otherwise, only those cells with an increase of I CaL density of Ͼ10% after drug application were considered responding cells and included into the statistics. The membrane capacity was measured by applying a voltage ramp 16 or by using appropriate software (MFK). Current densities are expressed as the I CaL peak value per capacity. The results are presented as meanϮSEM for n cells. The statistical significance of mean values was determined by Student t test for unpaired data. If not stated otherwise, the 2 pools of data were considered to be significantly different at PϽ0.01.
Investigation of the Establishment of ␤-Adrenergic Signal Transduction During Development
The functional coupling of different components of the ␤-adrenergic signaling cascade was studied during cardiomyocyte development. For this purpose, I CaL peak amplitude was measured using different agents. Key molecules involved in signal transduction and specific molecular tools testing their functions are shown schematically in Figure 1 . The functional expression of ␤-adrenergic receptors was tested by extracellular application of isoproterenol (1 mol/L). The function of AC was tested by its specific activator, forskolin (1 mol/L). Maximum stimulation of I CaL by cAMP was evaluated by cell dialysis with the cAMP analog 8-bromo-cAMP (8-Br-cAMP; 400 mol/L). The function of phosphodiesterases (PDEs) was tested by using the nonselective inhibitor isobutylmethylxanthine (IBMX) as well as the selective inhibitors EHNA (Erythro-9-[2-hydroxy-3-nonyl]adenine), milrinone, and rolipram for the various PDE isoforms. The receptor-mediated phosphorylation was investigated by coapplication of forskolin (1 mol/L) and the thiophosphorylating compound ATP-␥-S (2 mmol/L via patch pipette). The effect of Ca 2ϩ channel phosphorylation was tested by cell dialysis with the catalytic subunit of PKA (7 mol/L). ATP-␥-S (1 mmol/L) was added into the pipette solution in addition to the catalytic subunit of PKA to make channel phosphorylation irreversible. To test the direct stimulation of I CaL via G s protein, isoproterenol was applied extracellularly when cells were dialyzed with 10 mol/L of PKA inhibitor (PKI) and 1 mmol/L GTP-␥-S. Okadaic acid (10 mol/L) was used as a phosphatase type 1 and type 2A inhibitor.
Source of Substances
Forskolin was purchased from Serva, the catalytic subunit of PKA from Promega, and PKI 5-24 (lot LK-102) from Calbiochem. Cell cultivation medium, FCS, and all other substances for cell cultures were purchased from Gibco BRL. All the other substances were purchased from Sigma Chemical Co.
Results
Isoproterenol, Forskolin, and 8-Br-cAMP Stimulated I CaL in LDS but not VEDS Cardiomyocytes
The effect of isoproterenol on I CaL was different in VEDS and LDS cardiomyocytes. Although I CaL was insensitive to isoproterenol in VEDS cardiomyocytes (nϭ28), I CaL was stimulated by isoproterenol in all (nϭ24) LDS cardiomyocytes assayed (see examples in Figure 2 ), suggesting the establishment of a functional ␤-adrenergic cascade during development. Peak current amplitudes changed insignificantly (remaining within 10% of initial value) during at least 5 minutes after isoproterenol application in VEDS cells (in 25 of 28 cells) within the entire range of tested voltages from Ϫ30 to 40 mV (Figure 2A ). In those 3 responding cells, the average increase in I CaL density was very small (16Ϯ5%). In contrast, in LDS cells, I CaL stimulation amounted to 70Ϯ8% (nϭ24, measured at 0 mV). The stimulation of I CaL was observed in the whole range of test potentials applied, from Ϫ30 to 40 mV ( Figure 2B ).
The different sensitivity of the cells to isoproterenol may be a result of the low expression of ␤-adrenoceptors, as has been previously reported for cardiomyocytes from the fetal murine heart. 25 If the low expression of ␤-adrenoceptors was the only reason for the unresponsiveness of VEDS cells to isoproterenol, I CaL would still be stimulated by either forskolin, an activator of AC or 8-Br-cAMP. We also noticed significant changes of I CaL sensitivity to both forskolin ( Figure  3A and 3B) and intracellular application of 8-Br-cAMP (400 mol/L) during development ( Figure 3C and 3D) . Whereas in VEDS cells forskolin or 8-Br-cAMP did not influence I CaL , all LDS cardiomyocytes were highly responsive to both drugs. I CaL density increase amounted to 82Ϯ12% (nϭ16) and 156Ϯ32% (nϭ12) in LDS cells treated with forskolin and 8-Br-cAMP, respectively (see Table for absolute values of I CaL densities). This indicated that the full functional coupling of the ␤-adrenergic signaling cascade was established only in LDS cardiomyocytes. Conversely, the lack of response to isoproterenol, forskolin, and 8-Br-cAMP in VEDS cardiomyocytes (see Figures 2 and 3 and Table) is consistent with a signaling defect at a number of levels in these cells.
I CaL Stimulation in EDS Cardiomyocytes
To determine the critical period for the development of the functional ␤-adrenergic signaling cascade, we tested on a "day-by-day" basis the effects of 8-Br-cAMP, isoproterenol, and forskolin on I CaL (Figure 4) . Most (71%, nϭ7) of 7ϩ3d myocytes responded to 8-Br-cAMP exposure with an average increase of I CaL density of 18.6Ϯ3.2%. Cells of 7ϩ4d stage (79%, nϭ14) responded with a significantly larger increase of I CaL density (68.2Ϯ12.1%). In 7ϩ5d cells, I CaL stimulation amounted to 84Ϯ21.8% (nϭ7, 100% response rate). An important finding was that all cells responded to 8-Br-cAMP after 7ϩ5d, suggesting that significant developmental changes occur during this short period from day 7ϩ3d to day 7ϩ4d in the EDS cells. However, during this transitory period, the stimulation of I CaL by isoproterenol still remained relatively small, 38.7Ϯ5.1% (nϭ20, 45% response rate, see Figure 4A and Table) .
A possible interpretation of these findings in EDS cells was a reduced expression of functional ␤-adrenoceptors and/or a defective coupling to AC. We tested therefore different components of the signal transduction cascade in EDS cells to identify the mechanism(s) responsible for the observed 
Effect of ATP-␥-S and Okadaic Acid on I CaL in EDS and LDS Cells
Because coapplication of forskolin plus ATP-␥-S in EDS cells caused a strongly increased stimulation of I CaL density compared with forskolin alone, an involvement of phosphatases was suspected. Therefore, the stimulatory effect of intracellular ATP-␥-S (2 mmol/L) application via the patch pipette was tested in EDS and LDS cells ( Figure 6A , 6B, and 6D). ATP-␥-S resulted in a large increase of the basal I CaL density (70.3Ϯ13%, nϭ5) in EDS cells, whereas it augmented I CaL slightly in LDS cells (9.7Ϯ15.6%, nϭ4, averaging all cells examined). A high intrinsic phosphatase activity in EDS cells was further confirmed by examining the effect of okadaic acid, an inhibitor of type 1 and type 2A phosphatases on I CaL density at this developmental stage. Infusion of okadaic acid (10 mol/L) via the patch pipette resulted in an increase of I CaL density by 22Ϯ5% (nϭ5) (Figure 6C and 6D ).
Functional Expression of PDEs in EDS Cells
Because 8-Br-cAMP stimulated I CaL significantly stronger (about 2 times) than forskolin in 7ϩ4d cells, an involvement of PDEs in cAMP degradation was suspected. Therefore, effects of nonselective and selective PDE inhibitors on I CaL density were examined ( Figure 7 ). IBMX, a nonselective PDE inhibitor, had a strong stimulatory effect on I CaL density (61Ϯ7.5%) in 7ϩ3d and 7ϩ4d cardiomyocytes in all cells tested (nϭ21). The PDE II inhibitor EHNA increased I CaL density by 30.2Ϯ7.4% in 89% of cells (nϭ9). The PDE III blocker milrinone stimulated I CaL density by 44.2Ϯ5.3% in 64% of the tested cells (nϭ17). Furthermore, the cAMPdependent PDE IV inhibitor rolipram increased I CaL density by 41Ϯ9.3% in 69% of cells tested (nϭ12).
I CaL Was Stimulated by Cell Dialysis With the Catalytic Subunit of PKA in Both VEDS and LDS Cells
The fact that I CaL in VEDS cells was not stimulated by forskolin or 8-Br-cAMP indicated that uncoupling of signal transduction at this very early developmental stage could also occur downstream to the ␤-adrenoceptor or AC, possibly as a result of unresponsiveness of the Ca 2ϩ channel molecule itself. However, I CaL was strongly stimulated in all VEDS cells tested (nϭ6) on intracellular application of the catalytic (9) nϭ8 (8) nϭ17 (17) nϭ16 (16) ForskolinϩATP-␥-S 13.8Ϯ2.4 9.8Ϯ0.9
Effects of Drugs Testing ␤-Adrenergic Enzymatic Cascade on I CaL Density
⅐ ⅐ ⅐ 21.1Ϯ2.9 20.3Ϯ1.7 ⅐ ⅐ ⅐ ⅐ ⅐ ⅐ nϭ19 (19) nϭ14 (14) 8 nϭ1 (7) nϭ5 (7) nϭ11 (14) nϭ7 (7) nϭ12 (12) PKA catalytic subunit 9.6Ϯ0.8 17.0Ϯ2.1
nϭ6 (6) nϭ10 (10) Shown are average I CaL densities before and after drug application. Only those cells that showed increase in I CaL density of Ͼ10% were considered as responding cells and were used for averaging. Number (n) of responding cells is shown along with total number of cells assayed (in parentheses).
subunit of PKA via the patch pipette. After establishment of the whole-cell configuration, I CaL density gradually increased. The increase of I CaL density attained saturation (increase by 213Ϯ25%, nϭ6) within 5 minutes of cell dialysis. A similar stimulatory effect induced by the catalytic subunit of PKA was observed in LDS cardiomyocytes (increase by 208Ϯ28%, nϭ10) as well as in ventricular cardiomyocytes isolated from adult mice (increase by 202Ϯ15%, nϭ3). This indicates that during all developmental stages, the channel itself or a closely associated protein can be effectively phosphorylated, leading to an increase of I CaL amplitude. The final I CaL density was higher in LDS cardiomyocytes than in VEDS cells (see Table) , reflecting an increase of I CaL density of Ϸ1.7 times during development (see also Reference 16).
I CaL Stimulation by a Membrane-Delimited Pathway in LDS but not VEDS Cardiomyocytes
In adult cardiomyocytes, a direct pathway for I CaL stimulation independent of cAMP-dependent phosphorylation is believed to be mediated via direct interaction of G s with Ca 2ϩ channels. 26 Therefore, the next set of experiments was designed to test whether ES cell-derived cardiomyocytes also developed this alternative pathway. To discriminate between these 2 pathways, the cAMP-dependent phosphorylation was prevented by cell dialysis with the peptide inhibitor 5-24, a known potent blocker of PKA activity. 27 In addition, GTP-␥-S (1 mmol/L) was included into the pipette to fully activate all available G s (see also Reference 28) .
Under these conditions, the amplitude of I CaL varied insignificantly with time. The reduction of I CaL remained within 10% during the first 10 minutes of cell dialysis, similar to control cells (see Figure 8A ). The stability of the I CaL amplitude was important for the evaluation of the ␤-adrenergic stimulation. To demonstrate that PKI completely blocked the PKA activation, we tested whether inclusion of PKI plus GTP-␥-S in the patch pipette prevented forskolin (1 mol/L)-mediated stimulation of I CaL in LDS cells. Indeed, I CaL density did not change on forskolin application in 6 cells 10 minutes after rupture of the cell membrane (see example in Figure 8B ). Accordingly, the isoproterenol effect was assayed 10 minutes after starting cell dialysis with PKI plus GTP-␥-S. I CaL was stimulated by isoproterenol ( Figure 8C ) in all LDS cardiomyocytes (nϭ8), suggesting the functional activity of the alternative pathway for I CaL regulation. The stimulating effect of isoproterenol on I CaL under these conditions was 31Ϯ7%.
The existence of a distinct G protein-dependent pathway for I CaL regulation was also investigated in VEDS cells. As shown in the present study, I CaL in VEDS cells was unresponsive to isoproterenol. The reason for this could be a relatively weak G protein activity because of low intracellular GTP.
To rule out this possibility, additional experiments were performed with VEDS cells, dialyzed with PKI and GTP-␥-S, using the identical experimental protocol as for LDS cardiomyocytes. None of VEDS cells (nϭ6) responded to isoproterenol ( Figure 8D ), suggesting the lack of this pathway during very early stages of cardiac development.
Discussion
In the present study, using the stimulation of I CaL as a functional assay, we have characterized important changes in the functional expression of components of the ␤-adrenergic signaling cascade occurring during early stages of cardiomyogenesis. Although VEDS cardiomyocytes were insensitive to ␤-adrenergic stimulation, LDS cardiomyocytes responded to isoproterenol with a large increase of I CaL density (by Ϸ70%), similarly as reported for mammalian cardiomyocytes during postnatal development (Ϸ100% 7 ). Our data are in line with reports that embryonic mouse and rat cardiomyocytes are unresponsive to ␤-adrenergic stimulation. 6, 29 In addition, the membrane-delimited pathway via direct Ca 2ϩ channel activation by G s previously reported for adult cardiomyocytes 26, 30 was absent in VEDS cells.
In the present study, we took advantage of the ES cellderived cardiomyogenesis to isolate cardiomyocytes at very early developmental stages, when the first contractions occurred. 16 Optical recordings of contractions of rat embryos indicated that the paired cardiac primordia are just fused at Table. the time of the first spontaneous contractions at the late period of the 3-somite stage. 31 In contrast to the ES cell differentiation system, access to the mammalian heart at such an early developmental stage is complicated. 31 For the VEDS and EDS cardiomyocytes, we developed an experimental protocol of relatively stable recordings of I CaL at physiological Ca 2ϩ concentrations and temperature (37°C). The latter is particularly important with respect to the high temperature sensitivity of the regulatory enzyme cascade examined in the present study. This experimental approach allowed the characterization of the mechanisms responsible for changes in the ␤-adrenergic modulation of I CaL that occurred during development.
Changes of I CaL Modulation During Development
The lack of ␤-adrenergic modulation in VEDS cardiomyocytes suggests that one or more components of the signaling cascade were missing or functionally inactive. To identify these components, we assayed the functional activity of different elements in the ␤-adrenergic enzymatic cascade. A key finding was that I CaL was strongly stimulated by cell dialysis with the catalytic subunit of PKA in both VEDS and LDS cardiomyocytes. In contrast to a previous report 6 in which fast current rundown was observed using Ba 2ϩ as a charge carrier, we could accurately measure the stimulating effect of the catalytic subunit of PKA on I CaL in VEDS cardiomyocytes. The catalytic subunit of PKA produced a maximal I CaL stimulation. Importantly, I CaL stimulation by the catalytic subunit of PKA was found to be similar (Ϸ3 times) in VEDS, LDS, and ventricular cardiomyocytes isolated from the adult mouse heart. These data provide strong evidence for similar structural properties of the Ca 2ϩ channel or a closely related protein during development at least in regard to phosphorylation sites. Because I CaL was strongly stimulated by the catalytic subunit of PKA but relatively insensitive to either forskolin or 8-Br-cAMP, one explanation for the lack of ␤-adrenergic modulation in VEDS cardiomyocytes could be a low expression of the PKA holoenzyme, as suggested by An et al. 6 The EDS cells proved to be particularly interesting, because forskolin and 8-Br-cAMP already had a stimulatory effect on I CaL density, but the majority of cells still were not stimulated by isoproterenol. Furthermore, we detected a strong stimulation of I CaL by the combined application of forskolin plus the thiophosphorylating agent ATP-␥-S. This indicated an involvement of phosphatases in the modulation of I CaL at this developmental stage. Our hypothesis was confirmed by the experimental observation that ATP-␥-S led to a pronounced stimulation of basal I CaL in EDS cells, whereas at the LDS cell stage only a small stimulation was seen, similarly as reported for guinea-pig ventricular cardiomyocytes. 32 These results were further corroborated by experiments using the phosphatase (type 1 and type 2A inhibitor) okadaic acid. 33 EDS cells dialyzed with okadaic acid displayed an increase of I CaL density, suggesting that there is an intrinsic AC activity as well as the functional expression of PKA leading to the phosphorylation of Ca 2ϩ channels at rest besides an intrinsic phosphatase activity. Because of the intrinsic AC activity, we tested whether cAMP degradation was controlled by intrinsic PDE activity. Indeed, application of the nonselective PDE inhibitor IBMX caused a strong increase of I CaL density. The use of selective PDE inhibitors confirmed the functional expression of the cGMP-dependent type II and III and the cAMP-dependent type IV PDE isoforms. Thus, EDS cells are characterized by high intrinsic AC activity, which is counterbalanced by high intrinsic activity of PDEs and phosphatases.
The strong I Ca stimulation by ␤-adrenergic agonists in the presence of ATP-␥-S has been previously demonstrated in adult cardiomyocytes. 34 Interestingly, forskolin plus ATP-␥-S led to a much stronger stimulation compared with forskolin alone in 7ϩ4d cells, whereas in 7ϩ3d cells this effect was significantly less pronounced. This suggests that at 7ϩ3d, not all ␤-adrenergic signaling components are fully functional, and, therefore, the role of phosphatases is less important. One day later, however, nearly full coupling is established, and a strong functional role of phosphatases in the dephosphoryla- tion of stimulated I CaL , even more pronounced than in LDS cells, is observed.
We also tested for the establishment of the membranedelimited pathway for I CaL regulation via direct interaction of G s and the Ca 2ϩ channel. This modulatory pathway was found only in LDS but not VEDS cardiomyocytes. One of the possible reasons for the lack of both the membrane-delimited and the cAMP-mediated functional coupling of ␤-adrenoceptors may be a low level of the G s protein. 35 This is in line with the observation that in the mouse embryonic heart, ␤-adrenoceptors appear before a detectable heart rate response to isoproterenol. 25 Also, important developmental changes in the coupling between ␤-adrenoceptors and G proteins have been recently reported for fetal rat heart. 36
Possible Physiological Significance
Functional abnormalities of the cardiac sympathetic nervous system during development were suggested to be involved in the genesis of cardiac arrhythmias, particularly in sudden infant death syndrome. 37 Depressed function of ␤-adrenoceptors, 38 deficient production of cAMP, 39 and altered expression of G proteins 40 are characteristic for cardiomyocytes of failing hearts. Furthermore, an altered coupling of G proteins was suggested to account for decreased stimulation of I CaL by ␤-adrenergic agonists in hypertrophied 8 and diabetic 41 hearts. The ␤-adrenergic receptor system in heart failure is markedly desensitized due to, at least in part, altered expression of ␤-adrenergic receptor kinase acting in concert with an inhibitor protein, ␤-arrestin. 42 In addition, cardiomyocytes from failing hearts have an altered program of gene expression. Many studies demonstrate that cardiac hypertrophy as well as heart failure is associated with reexpression of an ensemble of genes characteristic of the embryonic heart. 10, 11 These findings clearly show that detailed knowledge about the establishment of the ␤-adrenergic signaling cascade during development is important for a better understanding of abnormalities in signaling detected in heart disease. Because cardiac disease states are characterized by hyporesponsiveness to ␤-adrenergic agonists, it is tempting to speculate that high PDE as well as phosphatase activities may contribute, similar to our findings in EDS cells, to this functional disorder.
